How Sleep Biomarkers Improve Clinical Development and Clinical Assessment in Depression, Upcoming Webinar Hosted by Xtalks
Sleep is one of the most powerful yet underutilized biomarkers in depression drug development, with objective sleep physiology offering insights into patient stratification, treatment response prediction, and pharmacodynamic signaling that traditional endpoints and patient-reported...
View original →